MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krejcí, A.
Right arrow Articles by Tucek, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krejcí, A.
Right arrow Articles by Tucek, S.

Vol. 60, Issue 4, 761-767, October 2001

Changes of Cooperativity between N-Methylscopolamine and Allosteric Modulators Alcuronium and Gallamine Induced by Mutations of External Loops of Muscarinic M3 Receptors

Alena Krejcí and Stanislav Tucek

Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic

To clarify the involvement of specific domains of muscarinic receptors in the action of allosteric modulators, muscarinic M3 receptors (on which allosteric interactions are weak) were genetically modified to become more similar to M2 receptors (on which allosteric interactions are strong) and were expressed in COS-7 cells. Affinity for allosteric modulator gallamine was enhanced 25- to 50-fold by modifications of the third external loop (o3) and the negative effect of gallamine on the affinity for classical antagonist N-[3H]methylscopolamine ([3H]NMS) was augmented. Affinity for alcuronium became 3-fold higher after the o3 loop of M3 receptors was made identical with the o3 loop of M2 receptors, and alcuronium acquired positive influence on the affinity for [3H]NMS. This is the first instance of inducing positive cooperativity on muscarinic receptors by genetic manipulation. Transferring whole o2 loop from M2 to M3 receptors substantially enhanced affinities for gallamine and alcuronium without augmenting their negative action on [3H]NMS binding. In contrast, effects of simply adding two negative charges into the o2 loop of M3 receptors were small. Removal of Arg from o1 loop abolished the negative effect of gallamine but not of alcuronium on [3H]NMS binding at equilibrium. Data point to an important role of o3 loop in the mechanism of the positive and negative cooperativity between [3H]NMS and alcuronium and gallamine, respectively, and in the binding of both modulators to M2 receptors and reveal independence between mutation-induced changes in the affinity for a modulator and in the magnitude and direction of the allosteric effect of the modulator.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Y. Chan, D. L. McKinzie, S. Bose, S. N. Mitchell, J. M. Witkin, R. C. Thompson, A. Christopoulos, S. Lazareno, N. J. M. Birdsall, F. P. Bymaster, et al.
Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
PNAS, August 5, 2008; 105(31): 10978 - 10983.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. B. Mazzone, N. Mori, M. Burman, M. Palovich, K. E. Belmonte, and B. J. Canning
Fluorescent styryl dyes FM1-43 and FM2-10 are muscarinic receptor antagonists: intravital visualization of receptor occupancy
J. Physiol., August 15, 2006; 575(1): 23 - 35.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Prilla, J. Schrobang, J. Ellis, H.-D. Holtje, and K. Mohr
Allosteric Interactions with Muscarinic Acetylcholine Receptors: Complex Role of the Conserved Tryptophan M2422Trp in a Critical Cluster of Amino Acids for Baseline Affinity, Subtype Selectivity, and Cooperativity
Mol. Pharmacol., July 1, 2006; 70(1): 181 - 193.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Fruchart-Gaillard, G. Mourier, C. Marquer, A. Menez, and D. Servent
Identification of Various Allosteric Interaction Sites on M1 Muscarinic Receptor Using 125I-Met35-Oxidized Muscarinic Toxin 7
Mol. Pharmacol., May 1, 2006; 69(5): 1641 - 1651.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X.-P. Huang, S. Prilla, K. Mohr, and J. Ellis
Critical Amino Acid Residues of the Common Allosteric Site on the M2 Muscarinic Acetylcholine Receptor: More Similarities than Differences between the Structurally Divergent Agents Gallamine and Bis(ammonio)alkane-Type Hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide
Mol. Pharmacol., September 1, 2005; 68(3): 769 - 778.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Jakubik, A. Krejci, and V. Dolezal
Asparagine, Valine, and Threonine in the Third Extracellular Loop of Muscarinic Receptor Have Essential Roles in the Positive Cooperativity of Strychnine-Like Allosteric Modulators
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 688 - 696.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F.-Y. Zeng, A. J. McLean, G. Milligan, M. Lerner, D. T. Chalmers, and D. P. Behan
Ligand Specific Up-Regulation of a Renilla reniformis Luciferase-Tagged, Structurally Unstable Muscarinic M3 Chimeric G Protein-Coupled Receptor
Mol. Pharmacol., December 1, 2003; 64(6): 1474 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
U. Voigtlander, K. Johren, M. Mohr, A. Raasch, C. Trankle, S. Buller, J. Ellis, H.-D. Holtje, and K. Mohr
Allosteric Site on Muscarinic Acetylcholine Receptors: Identification of Two Amino Acids in the Muscarinic M2 Receptor That Account Entirely for the M2/M5 Subtype Selectivities of Some Structurally Diverse Allosteric Ligands in N-Methylscopolamine-Occupied Receptors
Mol. Pharmacol., July 1, 2003; 64(1): 21 - 31.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics